Publication:
Prognostic Value of the Neutrophil-Lymphocyte Ratio and CA 19-9 in Predicting Survival Inpatients with Metastatic Pancreatic Cancer

dc.contributor.authorDede, I.
dc.contributor.authorCetin, M.
dc.contributor.authorCetin, S.
dc.date.accessioned2020-06-21T13:06:31Z
dc.date.available2020-06-21T13:06:31Z
dc.date.issued2018
dc.departmentOMÜen_US
dc.department-temp[Dede, I.] Mustafa Kemal Univ, Fac Med, Oncol, Antakya, Turkey -- [Cetin, M.] Mustafa Kemal Univ, Med Microbiol, Antakya, Turkey -- [Cetin, S.] Ondokuz Mayis Univ, Biostat, Samsun, Turkey --en_US
dc.description43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANYen_US
dc.description.abstracten_US
dc.description.sponsorshipEuropean Soc Med Oncol, Japanese Soc Med Oncolen_US
dc.identifier.endpage256en_US
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpage256en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11376
dc.identifier.volume29en_US
dc.identifier.wosWOS:000459277301329
dc.language.isoenen_US
dc.publisherOxford Univ Pressen_US
dc.relation.journalAnnals of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titlePrognostic Value of the Neutrophil-Lymphocyte Ratio and CA 19-9 in Predicting Survival Inpatients with Metastatic Pancreatic Canceren_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files